What We Do
Biotech Business
SVAX Innovation spearheads advanced research and development in biologics and vaccines, forging collaborations to deliver groundbreaking therapies. Our diverse portfolio encompasses proprietary products, including licensed intellectual property from regional partners, and co-development projects spanning all stages of the drug lifecycle. We fuel innovation to address unmet medical needs and improve global health outcomes.
Proprietary Products
SVAX leverages licensed intellectual property from local partners to develop innovative biologics and vaccines. Our focus is on advancing proprietary research to deliver transformative therapies tailored to regional healthcare demands.
Co-Development Products
SVAX collaborates with industry and academic partners to co-develop biologics and vaccines at various stages of the drug lifecycle, driving innovation and accelerating the availability of impactful treatments.